These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

363 related articles for article (PubMed ID: 30819690)

  • 1. Early hydroxychloroquine retinopathy: optical coherence tomography abnormalities preceding Humphrey visual field defects.
    Garrity ST; Jung JY; Zambrowski O; Pichi F; Su D; Arya M; Waheed NK; Duker JS; Chetrit Y; Miserocchi E; Giuffrè C; Kaden TR; Querques G; Souied EH; Freund KB; Sarraf D
    Br J Ophthalmol; 2019 Nov; 103(11):1600-1604. PubMed ID: 30819690
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LONGITUDINAL CHANGES IN EYES WITH HYDROXYCHLOROQUINE RETINAL TOXICITY.
    Allahdina AM; Chen KG; Alvarez JA; Wong WT; Chew EY; Cukras CA
    Retina; 2019 Mar; 39(3):473-484. PubMed ID: 30741731
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Perifoveal interdigitation zone loss in hydroxychloroquine toxicity leads to subclinical bull's eye lesion appearance on near-infrared reflectance imaging.
    Chew AL; Sampson DM; Chelva E; Khan JC; Chen FK
    Doc Ophthalmol; 2018 Feb; 136(1):57-68. PubMed ID: 29124422
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disparity between visual fields and optical coherence tomography in hydroxychloroquine retinopathy.
    Marmor MF; Melles RB
    Ophthalmology; 2014 Jun; 121(6):1257-62. PubMed ID: 24439759
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of Structural Changes on Multifocal Electroretinography in Patients With Use of Hydroxychloroquine.
    Borrelli E; Battista M; Cascavilla ML; Viganò C; Borghesan F; Nicolini N; Clemente L; Sacconi R; Barresi C; Marchese A; Miserocchi E; Modorati G; Bandello F; Querques G
    Invest Ophthalmol Vis Sci; 2021 Sep; 62(12):28. PubMed ID: 34581725
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of screening procedures in hydroxychloroquine toxicity.
    Marmor MF
    Arch Ophthalmol; 2012 Apr; 130(4):461-9. PubMed ID: 22159170
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of disease stage on progression of hydroxychloroquine retinopathy.
    Marmor MF; Hu J
    JAMA Ophthalmol; 2014 Sep; 132(9):1105-12. PubMed ID: 24922444
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optical coherence tomography angiography for screening of hydroxychloroquine-induced retinal alterations.
    Bulut M; Akıdan M; Gözkaya O; Erol MK; Cengiz A; Çay HF
    Graefes Arch Clin Exp Ophthalmol; 2018 Nov; 256(11):2075-2081. PubMed ID: 30159602
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A possible early sign of hydroxychloroquine macular toxicity.
    Brandao LM; Palmowski-Wolfe AM
    Doc Ophthalmol; 2016 Feb; 132(1):75-81. PubMed ID: 26792426
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Retinal toxicity of high-dose hydroxychloroquine in patients with chronic graft-versus-host disease.
    Navajas EV; Krema H; Hammoudi DS; Lipton JH; Simpson ER; Boyd S; Easterbrook M
    Can J Ophthalmol; 2015 Dec; 50(6):442-50. PubMed ID: 26651304
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recommendations on Screening for Chloroquine and Hydroxychloroquine Retinopathy (2016 Revision).
    Marmor MF; Kellner U; Lai TY; Melles RB; Mieler WF;
    Ophthalmology; 2016 Jun; 123(6):1386-94. PubMed ID: 26992838
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Subjective and objective screening tests for hydroxychloroquine toxicity.
    Cukras C; Huynh N; Vitale S; Wong WT; Ferris FL; Sieving PA
    Ophthalmology; 2015 Feb; 122(2):356-66. PubMed ID: 25444344
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Visual Field Sensitivity Prediction Using Optical Coherence Tomography Analysis in Hydroxychloroquine Toxicity.
    Jayakar G; De Silva T; Cukras CA
    Invest Ophthalmol Vis Sci; 2022 Jan; 63(1):15. PubMed ID: 35015028
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optical Coherence Tomography Minimum Intensity as an Objective Measure for the Detection of Hydroxychloroquine Toxicity.
    Allahdina AM; Stetson PF; Vitale S; Wong WT; Chew EY; Ferris FL; Sieving PA; Cukras C
    Invest Ophthalmol Vis Sci; 2018 Apr; 59(5):1953-1963. PubMed ID: 29677357
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Case Report: Hydroxychloroquine Retinopathy.
    Eldeeb M; Chan EW; Omar A
    Optom Vis Sci; 2018 Jun; 95(6):545-549. PubMed ID: 29787487
    [TBL] [Abstract][Full Text] [Related]  

  • 16. En Face Optical Coherence Tomography Imaging of the Photoreceptor Layers in Hydroxychloroquine Retinopathy.
    Ahn SJ; Joung J; Lee BR
    Am J Ophthalmol; 2019 Mar; 199():71-81. PubMed ID: 30448463
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spectral-domain optical coherence tomography and adaptive optics may detect hydroxychloroquine retinal toxicity before symptomatic vision loss.
    Stepien KE; Han DP; Schell J; Godara P; Rha J; Carroll J
    Trans Am Ophthalmol Soc; 2009 Dec; 107():28-33. PubMed ID: 20126479
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rapid Onset of Retinal Toxicity From High-Dose Hydroxychloroquine Given for Cancer Therapy.
    Leung LS; Neal JW; Wakelee HA; Sequist LV; Marmor MF
    Am J Ophthalmol; 2015 Oct; 160(4):799-805.e1. PubMed ID: 26189086
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative assessment of outer retinal layers and ellipsoid zone mapping in hydroxychloroquine retinopathy.
    Ugwuegbu O; Uchida A; Singh RP; Beven L; Hu M; Kaiser S; Srivastava SK; Ehlers JP
    Br J Ophthalmol; 2019 Jan; 103(1):3-7. PubMed ID: 30190364
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Retinal toxicity associated with hydroxychloroquine and chloroquine: risk factors, screening, and progression despite cessation of therapy.
    Michaelides M; Stover NB; Francis PJ; Weleber RG
    Arch Ophthalmol; 2011 Jan; 129(1):30-9. PubMed ID: 21220626
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.